4//SEC Filing
Kemps-Polanco Reshema 4
Accession 0001127602-24-015523
CIK 0001100682other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 5:34 PM ET
Size
8.8 KB
Accession
0001127602-24-015523
Insider Transaction Report
Form 4
Kemps-Polanco Reshema
Director
Transactions
- Award
Common Stock
2024-05-13$228.41/sh+285$65,097→ 1,014 total - Award
Common Stock
2024-05-13$228.41/sh+559$127,681→ 729 total - Award
Stock Options (Right to Buy)
2024-05-13$228.41/sh+1,311$299,446→ 1,311 totalExercise: $228.41From: 2025-05-13Exp: 2034-05-13→ Common Stock (1,311 underlying)
Footnotes (3)
- [F1]The unvested restricted stock units vest upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders.
- [F2]The grant was made in lieu of director service fees for the term commencing May 8, 2024. The restricted stock units vest upon the earlier of 5/13/2025, or the business day prior to the Company's next annual meeting of shareholders.
- [F3]The stock options become exercisable upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders.
Documents
Issuer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
CIK 0001100682
Entity typeother
Related Parties
1- filerCIK 0002009357
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 5:34 PM ET
- Size
- 8.8 KB